Integrative Neuroscience of Cognition and Aging is representing at #ADPD2023 with talks from @k8onuska, Hayley Shanks, Taylor W. Schmitz this Friday and a poster from Bahaaldin Helal Screenshots attached for reference.

Double congratulations to Bahaaldin Helal for successful defense of your Master of Engineering Science and admission to University of Toronto med school!

Congratulations Dr. Sudesna Chakraborty @SudesnaC!!! Newly minted PhD! Read about some of Sudesna's work here: biorxiv.org/content/10.110…

(part 2) Hayley Shanks discusses the p75 neurotrophin receptor as a drug target for promoting neuronal resilience to Alzheimer's disease dx.doi.org/10.14283/jpad.…. With collaborators Frank Longo and Stephen Massa Stanford Medicine and an assist from @k8onuska.

Each of these reviews has a companion primary research article forthcoming - Stay tuned!

#SchulichMedDent's PhD candidate Hayley Shanks may play for Western's women's football team, but off the field, she's tackling Alzheimer’s disease through her research. Read more in this story by Makaila Atsonglo. ⤵️ brnw.ch/21wGzrh

Congrats to our own Taylor W. Schmitz and all other awardees! Western innovators receive Early Researchers Awards - Western News news.westernu.ca/2024/03/wester…

A phase 1 trial of a p75 #neurotrophin receptor, LM11A-31, in mild to moderate #Alzheimers disease suggests that p75 modulation is safe and attenuates measures of degeneration. #p75NTR Hayley Shanks Integrative Neuroscience of Cognition and Aging Taylor W. Schmitz Western University nature.com/articles/s4159…

A paper in Nature Medicine reports that a phase 2a trial of drug candidate LM11A-31 in mild to moderate Alzheimer disease suggests that p75 neurotrophin receptor modulation is safe and attenuates measures of degeneration. go.nature.com/4bKzJhx